New treatment for inherited retinal dystrophies


NHS estimates just under 90 people in England will be eligible for the treatment.
People with a mutation of the RPE65 gene will be suitable for the new treatment.
In the short term, Luxturna improves vision and prevents the condition from getting worse.
Treatment will become available after NICE expects will publish its final guidance, from January 2020.

Gene therapy presents injecting the healthy gene directly in the eye to produce working protein

Mentioned in this article: National Institute for Health and Care Excellence (NICE), NHS.

Read full article on BBC website
More Gene Therapy information, news and resources
More Health information, news and resources